BIOMATERIALS
Scope & Guideline
Unveiling Breakthroughs in Biomaterials Engineering
Introduction
Aims and Scopes
- Biomaterials for Regenerative Medicine:
Research in this area focuses on the development and application of biomaterials that can support tissue regeneration and repair, including scaffolds, hydrogels, and 3D printed constructs designed to enhance healing in various tissues. - Nanomedicine and Drug Delivery Systems:
This scope encompasses the design and application of nanomaterials for targeted and controlled drug delivery, enhancing therapeutic efficacy while minimizing side effects, particularly in cancer treatment and chronic diseases. - Bioengineering and Tissue Engineering:
The journal highlights studies that integrate engineering principles with biological systems, focusing on the creation of functional tissues and organs, including organ-on-a-chip technologies and bioprinting. - Immunomodulation and Therapeutic Applications:
Research that explores how biomaterials can modulate immune responses to improve therapeutic outcomes, particularly in cancer immunotherapy and regenerative medicine. - Biocompatibility and Safety Evaluation:
The journal publishes studies assessing the biocompatibility, toxicity, and long-term effects of biomaterials in biological systems, which are critical for their clinical translation. - Smart Biomaterials and Responsive Systems:
This area includes the development of materials that respond to environmental stimuli (e.g., pH, temperature, light) for dynamic therapeutic applications.
Trending and Emerging
- Advanced Nanotherapeutics:
There is a growing emphasis on the development of nanomaterials that can deliver drugs or therapeutic agents with high precision, including nanocarriers that enhance the efficacy of immunotherapies and chemotherapies. - 3D Bioprinting and Organ-on-a-Chip Technologies:
The trend towards creating complex tissue structures using 3D bioprinting techniques is increasing, along with the development of organ-on-a-chip systems that mimic human organ functions for drug testing and disease modeling. - Biomaterials for Cancer Immunotherapy:
Research is trending towards the use of biomaterials as platforms for cancer immunotherapy, focusing on how these materials can enhance immune responses and target tumor microenvironments. - Smart and Responsive Biomaterials:
There is an emerging interest in biomaterials that respond to specific stimuli (light, temperature, pH), allowing for on-demand drug release and dynamic therapeutic applications. - Microenvironment Engineering:
An increasing number of studies are focusing on how the engineered microenvironment can influence cell behavior, particularly in the context of stem cell therapy and tissue regeneration. - Sustainable and Green Biomaterials:
There is a rising trend towards developing environmentally friendly biomaterials derived from natural sources, emphasizing sustainability and biocompatibility.
Declining or Waning
- Traditional Biomaterials without Functionalization:
There has been a noticeable decrease in studies focusing solely on traditional biomaterials (such as simple hydrogels or polymers) without advanced functionalization or modification to enhance their properties or applications. - In vitro Studies without Translation to In Vivo Models:
Research that remains solely within in vitro studies without progressing to in vivo validation is declining, as there is a greater emphasis on translational research that can lead to practical applications in clinical settings. - Non-targeted Drug Delivery Approaches:
As precision medicine becomes more prominent, there is a waning interest in non-targeted drug delivery systems, with more focus shifting towards targeted and personalized therapies. - Static Biomaterial Studies:
Static studies that do not incorporate dynamic or responsive elements in biomaterials are becoming less frequent, as there is a growing interest in materials that can adapt to physiological conditions.
Similar Journals
JOURNAL OF CONTROLLED RELEASE
Pioneering the future of controlled release technologies.JOURNAL OF CONTROLLED RELEASE is a premier academic journal published by Elsevier that is dedicated to advancing the field of pharmaceutical science with a focus on drug delivery systems. Established in 1984, the journal has consistently served as a vital platform for disseminating high-quality research and innovative ideas in the area of controlled release technologies. With an impressive impact factor and ranking in the Q1 category of Pharmaceutical Science, it ranks #3 out of 183 in Scopus for its field, reflecting its influence and significance within the academic community, as noted by its percentile of 98th. The journal encompasses a wide range of topics, including polymer science, pharmacokinetics, and bioengineering, ensuring it remains at the forefront of pharmaceutical advancements. While currently not offering open access options, the journal serves a diverse audience of researchers, professionals, and students who are eager to push the boundaries of knowledge in drug delivery and therapeutics. For those looking to make impactful contributions in this dynamic field, JOURNAL OF CONTROLLED RELEASE is an essential resource for both foundational studies and cutting-edge research findings.
Advanced NanoBiomed Research
Bridging Disciplines for a Healthier TomorrowAdvanced NanoBiomed Research is a pioneering open-access journal committed to advancing the interdisciplinary field of nanobiotechnology, published by WILEY-V C H VERLAG GMBH. Since its inception in 2021, this journal has provided a platform for innovative research that bridges the gap between engineering, medicine, and materials science. With impressive rankings in Scopus, positioning it within the top quartiles of various categories, Advanced NanoBiomed Research aims to disseminate high-quality research that contributes to the understanding and application of nanomaterials in biomedical contexts. As it encompasses a wide scope—from applied microbiology to biomaterials—it serves as an essential resource for researchers, professionals, and students eager to explore the cutting-edge developments in the field. The journal promotes a collaborative environment where emerging ideas can flourish, ensuring that vital advancements in nanobiomedicine can be shared and built upon within the scientific community.
Biomaterials Advances
Bridging Science and Application in Biomaterials AdvancesBiomaterials Advances is a premier journal published by Elsevier, dedicated to the rapidly evolving field of biomaterials. Established in the United Kingdom, this open-access journal aims to disseminate high-quality, peer-reviewed research that explores innovative biomaterial designs and their applications in bioengineering and biomedical engineering. With an impressive 2023 impact factor reflected in its Q1 rankings across multiple categories—including Bioengineering, Biomaterials, and Biomedical Engineering—Biomaterials Advances stands out as a critical platform for scholars and practitioners faced with advancing technologies and methodologies in the realm of materials science. Covering a broad range of topics, from biocompatibility to tissue engineering, this journal provides an inclusive forum for researchers seeking to contribute to the field. Its Scopus rankings further affirm its position as a leading resource, with notable standings in Biomedical Engineering (Rank #13), Biomaterials (Rank #8), and Bioengineering (Rank #11), all within the top percentiles. Researchers and students alike are encouraged to contribute and engage with the latest findings and innovations in biomaterials through this valuable publication.
JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
Transforming Ideas into Bioactive SolutionsJOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS, published by SAGE PUBLICATIONS LTD, serves as a pivotal platform for disseminating innovative research in the fields of bioengineering, biomaterials, materials chemistry, and polymers. With an ISSN of 0883-9115 and an E-ISSN of 1530-8030, this journal is committed to the advancement of knowledge relating to the interaction of polymers within biological systems and their compatibility in various applications. Operating since 1986, the journal has garnered a respectable presence, ranked in the Q3 quartile across multiple categories in 2023, indicating its relevance and contribution to these dynamic fields. Although not open access, the journal ensures that high-quality research is accessible to subscribers and institutions, reinforcing its importance for researchers, professionals, and students aiming to stay abreast of advancements in polymer science and biocompatibility. By fostering interdisciplinary communication and collaboration, the JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS continues to play a crucial role in shaping the future of material applications in health, technology, and industry.
Materials Today Bio
Empowering researchers with open access to vital scientific advancements.Materials Today Bio, published by Elsevier, is an esteemed open-access journal dedicated to advancing the fields of bioengineering, biomaterials, and biomedical engineering. Since its inception in 2019, this journal has quickly made a name for itself, currently ranked Q1 in multiple categories including Bioengineering, Biomaterials, and Biotechnology, reflecting its exceptional quality and relevance in the rapidly evolving landscape of bio-related sciences. With an impressive Scopus ranking positioning it in the top 25% of its categories, Materials Today Bio provides a vital platform for researchers and professionals to share cutting-edge discoveries and innovative applications that bridge the gap between materials science and biological studies. Accessible to a global audience, this journal not only fosters collaboration among the scientific community but also aims to highlight significant advancements in cell and molecular biology, making it an indispensable resource for students and seasoned experts alike. The journal's commitment to open access since 2019 underscores its dedication to disseminating knowledge widely, ensuring that crucial findings reach those who can benefit from them the most.
APL Bioengineering
Transforming Ideas into Bioengineering BreakthroughsAPL Bioengineering is a premier open-access journal published by AIP Publishing, dedicated to advancing the field of bioengineering and its interdisciplinary applications. Established in 2017, this journal serves as a vital platform for researchers, professionals, and students interested in the critical intersections of bioengineering, biomaterials, biomedical engineering, and biophysics. With an impressive impact factor and consistent rankings in the Q1 category across multiple domains, including biochemistry and materials science, APL Bioengineering has positioned itself among the top journals in its field. The journal aims to publish innovative original research, comprehensive reviews, and insightful case studies that further the understanding and application of bioengineering principles. Since its inception, APL Bioengineering has fostered a community of thought leaders, providing open access to ensure broad dissemination of knowledge and advancements that underpin the future of biomedical innovation.
ACS Biomaterials Science & Engineering
Connecting Research and Application for a Healthier TomorrowACS Biomaterials Science & Engineering, published by the American Chemical Society, serves as a premier platform for the latest advancements and research in the fields of biomaterials and biomedical engineering. With an impressive impact factor and a strong reputation reflected in its ranking—Q2 in Biomaterials and Q1 in Biomedical Engineering—the journal attracts a diverse and engaged readership. Since its inception in 2015, it has aimed to foster innovation by publishing high-quality research articles, reviews, and perspectives on the synthesis, characterization, and application of biomaterials. Researchers and professionals benefit from the journal's rigorous peer-review process and its focus on translational science, making it essential for those looking to stay at the forefront of biomaterials research. Located in Washington, DC, USA, the journal plays a pivotal role in connecting academic and industrial sectors, ultimately driving advancements that impact biomedicine and related fields.
Acta Biomaterialia
Shaping the Landscape of Biomedical InnovationActa Biomaterialia, published by Elsevier Science Ltd, is a leading journal in the fields of biochemistry, biomaterials, biomedical engineering, biotechnology, and molecular biology. With an ISSN of 1742-7061 and an E-ISSN of 1878-7568, this prestigious journal has secured a remarkable position in the academic community, evidenced by its inclusion in the Q1 category across multiple disciplines for 2023. It ranks impressively at #21 in biochemistry, #16 in biomedical engineering, #18 in biotechnology, and #11 in biomaterials, reflecting its high impact and relevance to ongoing research and development. The journal provides a platform for disseminating innovative research and advancements in the design and application of biomaterials, contributing to scientific discussions that propel the field forward. Although it does not currently offer open access options, Acta Biomaterialia continues to attract contributions that advance our understanding of biomaterials and their interactions with biological systems, ensuring that researchers, professionals, and students remain informed about the latest trends and breakthroughs in this rapidly evolving area of study.
VIEW
Exploring Innovations at the Intersection of Science and Medicine.VIEW is a prestigious journal published by WILEY that focuses on the rapidly evolving fields of Biomaterials and Biomedical Engineering. Since its inception in 2020, VIEW has established itself as an open-access platform dedicated to disseminating high-quality research and innovation within these disciplines. With an impressive impact factor that places it in the Q1 category of both Biomaterials and Biomedical Engineering, VIEW ranks among the top journals in its field, boasting a 91st percentile ranking in Biomedical Engineering and an 85th percentile ranking in Materials Science. Researchers, professionals, and students are encouraged to utilize this invaluable resource, as it provides a comprehensive view of current advancements and future trends in biomaterial science and engineering. Positioned in the United Kingdom, VIEW operates as a vital scholarly communication link, fostering collaboration and knowledge sharing within an ever-growing global community.
Materials Science & Engineering C-Materials for Biological Applications
Pioneering new frontiers in biomaterials research.Materials Science & Engineering C-Materials for Biological Applications is a premier journal published by ELSEVIER, dedicated to advancing the field of biomaterials through interdisciplinary research. With a robust ISSN of 0928-4931, this journal has made its mark in the realms of Chemical Engineering and Materials Science, achieving impressive Scopus rankings within its categories, namely Rank #16/151 in Bioengineering (89th percentile) and Rank #13/112 in Biomaterials (88th percentile). Although the journal's coverage in Scopus has been discontinued since 2021, it remains a critical resource for researchers, professionals, and students eager to explore innovative materials and their applications in biological contexts. The journal’s open access policy enhances its accessibility, fostering a global exchange of knowledge and inspiring future advancements in the field of materials science.